array(40) {
  [0]=>
  string(4) "1730"
  ["article_id"]=>
  string(4) "1730"
  [1]=>
  string(82) "GPhC expects more than 2,000 pharmacists to leave the register by end of 2018/2019"
  ["article_title"]=>
  string(82) "GPhC expects more than 2,000 pharmacists to leave the register by end of 2018/2019"
  [2]=>
  string(144) "More than 2,000 pharmacists are expected to leave the pharmacy register in 2019, according to forecasts from the General Pharmaceutical Council."
  ["short_description"]=>
  string(144) "More than 2,000 pharmacists are expected to leave the pharmacy register in 2019, according to forecasts from the General Pharmaceutical Council."
  [3]=>
  string(144) "More than 2,000 pharmacists are expected to leave the pharmacy register in 2019, according to forecasts from the General Pharmaceutical Council."
  ["description"]=>
  string(144) "More than 2,000 pharmacists are expected to leave the pharmacy register in 2019, according to forecasts from the General Pharmaceutical Council."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(160) "https://www.pharmaceutical-journal.com/news-and-analysis/news/gphc-expects-more-than-2000-pharmacists-to-leave-the-register-by-end-of-2018/2019/20206127.article"
  ["blog_url"]=>
  string(160) "https://www.pharmaceutical-journal.com/news-and-analysis/news/gphc-expects-more-than-2000-pharmacists-to-leave-the-register-by-end-of-2018/2019/20206127.article"
  [15]=>
  string(19) "2019-02-11 21:55:00"
  ["add_date"]=>
  string(19) "2019-02-11 21:55:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:36"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:36"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1733"
  ["article_id"]=>
  string(4) "1733"
  [1]=>
  string(56) "Qualified Persons: seven things pharmacists need to know"
  ["article_title"]=>
  string(56) "Qualified Persons: seven things pharmacists need to know"
  [2]=>
  string(113) "Carol Candlish and Kina Vyas explain the role of a Qualified Person and how pharmacists in the UK can become one."
  ["short_description"]=>
  string(113) "Carol Candlish and Kina Vyas explain the role of a Qualified Person and how pharmacists in the UK can become one."
  [3]=>
  string(113) "Carol Candlish and Kina Vyas explain the role of a Qualified Person and how pharmacists in the UK can become one."
  ["description"]=>
  string(113) "Carol Candlish and Kina Vyas explain the role of a Qualified Person and how pharmacists in the UK can become one."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "12"
  ["rss_id"]=>
  string(2) "12"
  [14]=>
  string(160) "https://www.pharmaceutical-journal.com/careers-and-jobs/careers-and-jobs/career-feature/qualified-persons-seven-things-pharmacists-need-to-know/20206023.article"
  ["blog_url"]=>
  string(160) "https://www.pharmaceutical-journal.com/careers-and-jobs/careers-and-jobs/career-feature/qualified-persons-seven-things-pharmacists-need-to-know/20206023.article"
  [15]=>
  string(19) "2019-02-11 20:52:00"
  ["add_date"]=>
  string(19) "2019-02-11 20:52:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:37"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:37"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1744"
  ["article_id"]=>
  string(4) "1744"
  [1]=>
  string(81) "Sanofi and Regeneron Offer Praluent (alirocumab) at a New Reduced U.S. List Price"
  ["article_title"]=>
  string(81) "Sanofi and Regeneron Offer Praluent (alirocumab) at a New Reduced U.S. List Price"
  [2]=>
  string(150) "BRIDGEWATER, N.J. and TARRYTOWN, N.Y., Feb. 11, 2019 /PRNewswire/ -- Praluent (alirocumab) will be made available at a new reduced U.S. list price of "
  ["short_description"]=>
  string(150) "BRIDGEWATER, N.J. and TARRYTOWN, N.Y., Feb. 11, 2019 /PRNewswire/ -- Praluent (alirocumab) will be made available at a new reduced U.S. list price of "
  [3]=>
  string(247) "BRIDGEWATER, N.J. and TARRYTOWN, N.Y., Feb. 11, 2019 /PRNewswire/ -- Praluent (alirocumab) will be made available at a new reduced U.S. list price of $5,850 annually, a 60% reduction from the original price, for both the 75 mg and 150 mg doses,..."
  ["description"]=>
  string(247) "BRIDGEWATER, N.J. and TARRYTOWN, N.Y., Feb. 11, 2019 /PRNewswire/ -- Praluent (alirocumab) will be made available at a new reduced U.S. list price of $5,850 annually, a 60% reduction from the original price, for both the 75 mg and 150 mg doses,..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(247) "https://www.drugs.com/clinical_trials/sanofi-regeneron-offer-praluent-alirocumab-new-reduced-u-s-list-price-18070.html?utm_source=ddc&utm_medium=rss&utm_campaign=Sanofi+and+Regeneron+Offer+Praluent+%28alirocumab%29+at+a+New+Reduced+U.S.+List+Price"
  ["blog_url"]=>
  string(247) "https://www.drugs.com/clinical_trials/sanofi-regeneron-offer-praluent-alirocumab-new-reduced-u-s-list-price-18070.html?utm_source=ddc&utm_medium=rss&utm_campaign=Sanofi+and+Regeneron+Offer+Praluent+%28alirocumab%29+at+a+New+Reduced+U.S.+List+Price"
  [15]=>
  string(19) "2019-02-11 13:02:42"
  ["add_date"]=>
  string(19) "2019-02-11 13:02:42"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:38"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:38"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1745"
  ["article_id"]=>
  string(4) "1745"
  [1]=>
  string(146) "Gilead Announces Topline Data From Phase 3 STELLAR-4 Study of Selonsertib in Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH)"
  ["article_title"]=>
  string(146) "Gilead Announces Topline Data From Phase 3 STELLAR-4 Study of Selonsertib in Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH)"
  [2]=>
  string(150) "FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 11, 2019-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that STELLAR-4, a Phase 3, randomized, doub"
  ["short_description"]=>
  string(150) "FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 11, 2019-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that STELLAR-4, a Phase 3, randomized, doub"
  [3]=>
  string(241) "FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 11, 2019-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that STELLAR-4, a Phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of selonsertib, an..."
  ["description"]=>
  string(241) "FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 11, 2019-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that STELLAR-4, a Phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of selonsertib, an..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/gilead-announces-topline-data-phase-3-stellar-4-study-selonsertib-compensated-cirrhosis-f4-due-18071.html?utm_source=ddc&utm_medium=rss&utm_campaign=Gilead+Announces+Topline+Data+From+Phase+3+STELLAR-4+Study+of+Selonsertib+in+Compensated+Cirrhosis+%28F4%29+Due+t"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/gilead-announces-topline-data-phase-3-stellar-4-study-selonsertib-compensated-cirrhosis-f4-due-18071.html?utm_source=ddc&utm_medium=rss&utm_campaign=Gilead+Announces+Topline+Data+From+Phase+3+STELLAR-4+Study+of+Selonsertib+in+Compensated+Cirrhosis+%28F4%29+Due+t"
  [15]=>
  string(19) "2019-02-11 13:02:33"
  ["add_date"]=>
  string(19) "2019-02-11 13:02:33"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:38"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:38"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1764"
  ["article_id"]=>
  string(4) "1764"
  [1]=>
  string(41) "FDA Cites Six Firms for GMP, Other Issues"
  ["article_title"]=>
  string(41) "FDA Cites Six Firms for GMP, Other Issues"
  [2]=>
  string(153) "&#nl        The FDA rapped six device facilities for a variety of deficiencies identified during inspections, including problems with CAPAs and medical d"
  ["short_description"]=>
  string(153) "&#nl        The FDA rapped six device facilities for a variety of deficiencies identified during inspections, including problems with CAPAs and medical d"
  [3]=>
  string(179) "&#nl        The FDA rapped six device facilities for a variety of deficiencies identified during inspections, including problems with CAPAs and medical device reporting.&#nl      "
  ["description"]=>
  string(179) "&#nl        The FDA rapped six device facilities for a variety of deficiencies identified during inspections, including problems with CAPAs and medical device reporting.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "19"
  ["rss_id"]=>
  string(2) "19"
  [14]=>
  string(80) "https://www.fdanews.com/articles/190169-fda-cites-six-firms-for-gmp-other-issues"
  ["blog_url"]=>
  string(80) "https://www.fdanews.com/articles/190169-fda-cites-six-firms-for-gmp-other-issues"
  [15]=>
  string(19) "2019-02-09 03:21:45"
  ["add_date"]=>
  string(19) "2019-02-09 03:21:45"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:39"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1765"
  ["article_id"]=>
  string(4) "1765"
  [1]=>
  string(52) "China Introduces Routine Overseas Device Inspections"
  ["article_title"]=>
  string(52) "China Introduces Routine Overseas Device Inspections"
  [2]=>
  string(158) "&#nl        China’s National Medical Products Administration is increasing its scrutiny of foreign manufacturers and will begin routine, risk-based ins"
  ["short_description"]=>
  string(158) "&#nl        China’s National Medical Products Administration is increasing its scrutiny of foreign manufacturers and will begin routine, risk-based ins"
  [3]=>
  string(258) "&#nl        China’s National Medical Products Administration is increasing its scrutiny of foreign manufacturers and will begin routine, risk-based inspections of foreign facilities to confirm they are in compliance with Chinese regulations.&#nl      "
  ["description"]=>
  string(258) "&#nl        China’s National Medical Products Administration is increasing its scrutiny of foreign manufacturers and will begin routine, risk-based inspections of foreign facilities to confirm they are in compliance with Chinese regulations.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "19"
  ["rss_id"]=>
  string(2) "19"
  [14]=>
  string(92) "https://www.fdanews.com/articles/190168-china-introduces-routine-overseas-device-inspections"
  ["blog_url"]=>
  string(92) "https://www.fdanews.com/articles/190168-china-introduces-routine-overseas-device-inspections"
  [15]=>
  string(19) "2019-02-09 03:18:35"
  ["add_date"]=>
  string(19) "2019-02-09 03:18:35"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:39"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1766"
  ["article_id"]=>
  string(4) "1766"
  [1]=>
  string(63) "HSCC Introduces Plan for Cybersecurity ‘By Design’"
  ["article_title"]=>
  string(63) "HSCC Introduces Plan for Cybersecurity ‘By Design’"
  [2]=>
  string(156) "&#nl        The Healthcare and Public Health Sector Coordinating Council (HSCC) has developed a new guide for managing the security of medical devices.&#nl "
  ["short_description"]=>
  string(156) "&#nl        The Healthcare and Public Health Sector Coordinating Council (HSCC) has developed a new guide for managing the security of medical devices.&#nl "
  [3]=>
  string(161) "&#nl        The Healthcare and Public Health Sector Coordinating Council (HSCC) has developed a new guide for managing the security of medical devices.&#nl      "
  ["description"]=>
  string(161) "&#nl        The Healthcare and Public Health Sector Coordinating Council (HSCC) has developed a new guide for managing the security of medical devices.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "19"
  ["rss_id"]=>
  string(2) "19"
  [14]=>
  string(88) "https://www.fdanews.com/articles/190167-hscc-introduces-plan-for-cybersecurity-by-design"
  ["blog_url"]=>
  string(88) "https://www.fdanews.com/articles/190167-hscc-introduces-plan-for-cybersecurity-by-design"
  [15]=>
  string(19) "2019-02-09 03:16:46"
  ["add_date"]=>
  string(19) "2019-02-09 03:16:46"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:39"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1767"
  ["article_id"]=>
  string(4) "1767"
  [1]=>
  string(56) "CDRH Seeks Stakeholder Input on 2019 Guidance Priorities"
  ["article_title"]=>
  string(56) "CDRH Seeks Stakeholder Input on 2019 Guidance Priorities"
  [2]=>
  string(158) "&#nl        FDA’s Center for Devices and Radiological Health called for feedback from stakeholders on its priorities for developing guidance for the ye"
  ["short_description"]=>
  string(158) "&#nl        FDA’s Center for Devices and Radiological Health called for feedback from stakeholders on its priorities for developing guidance for the ye"
  [3]=>
  string(177) "&#nl        FDA’s Center for Devices and Radiological Health called for feedback from stakeholders on its priorities for developing guidance for the year ahead.&#nl      "
  ["description"]=>
  string(177) "&#nl        FDA’s Center for Devices and Radiological Health called for feedback from stakeholders on its priorities for developing guidance for the year ahead.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "19"
  ["rss_id"]=>
  string(2) "19"
  [14]=>
  string(96) "https://www.fdanews.com/articles/190166-cdrh-seeks-stakeholder-input-on-2019-guidance-priorities"
  ["blog_url"]=>
  string(96) "https://www.fdanews.com/articles/190166-cdrh-seeks-stakeholder-input-on-2019-guidance-priorities"
  [15]=>
  string(19) "2019-02-09 03:15:04"
  ["add_date"]=>
  string(19) "2019-02-09 03:15:04"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:39"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1768"
  ["article_id"]=>
  string(4) "1768"
  [1]=>
  string(68) "Health Canada Maps Out Action Plan to Improve Device Safety, Quality"
  ["article_title"]=>
  string(68) "Health Canada Maps Out Action Plan to Improve Device Safety, Quality"
  [2]=>
  string(153) "&#nl        Health Canada released a three-part action plan aimed at improving how devices get on the market, strengthening monitoring and providing more"
  ["short_description"]=>
  string(153) "&#nl        Health Canada released a three-part action plan aimed at improving how devices get on the market, strengthening monitoring and providing more"
  [3]=>
  string(216) "&#nl        Health Canada released a three-part action plan aimed at improving how devices get on the market, strengthening monitoring and providing more information to consumers about the devices they use.&#nl      "
  ["description"]=>
  string(216) "&#nl        Health Canada released a three-part action plan aimed at improving how devices get on the market, strengthening monitoring and providing more information to consumers about the devices they use.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "19"
  ["rss_id"]=>
  string(2) "19"
  [14]=>
  string(107) "https://www.fdanews.com/articles/190165-health-canada-maps-out-action-plan-to-improve-device-safety-quality"
  ["blog_url"]=>
  string(107) "https://www.fdanews.com/articles/190165-health-canada-maps-out-action-plan-to-improve-device-safety-quality"
  [15]=>
  string(19) "2019-02-09 03:13:02"
  ["add_date"]=>
  string(19) "2019-02-09 03:13:02"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:39"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1769"
  ["article_id"]=>
  string(4) "1769"
  [1]=>
  string(74) "Notified Bodies Warn of Future Bottlenecks in Implementing New Device Regs"
  ["article_title"]=>
  string(74) "Notified Bodies Warn of Future Bottlenecks in Implementing New Device Regs"
  [2]=>
  string(153) "&#nl        The European Association for Medical Devices of Notified Bodies (Team-NB) is sounding alarms over the shortage of notified bodies to conduct "
  ["short_description"]=>
  string(153) "&#nl        The European Association for Medical Devices of Notified Bodies (Team-NB) is sounding alarms over the shortage of notified bodies to conduct "
  [3]=>
  string(262) "&#nl        The European Association for Medical Devices of Notified Bodies (Team-NB) is sounding alarms over the shortage of notified bodies to conduct audits and certify devicemakers in time to comply with the new European medical device regulations.&#nl      "
  ["description"]=>
  string(262) "&#nl        The European Association for Medical Devices of Notified Bodies (Team-NB) is sounding alarms over the shortage of notified bodies to conduct audits and certify devicemakers in time to comply with the new European medical device regulations.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "19"
  ["rss_id"]=>
  string(2) "19"
  [14]=>
  string(114) "https://www.fdanews.com/articles/190164-notified-bodies-warn-of-future-bottlenecks-in-implementing-new-device-regs"
  ["blog_url"]=>
  string(114) "https://www.fdanews.com/articles/190164-notified-bodies-warn-of-future-bottlenecks-in-implementing-new-device-regs"
  [15]=>
  string(19) "2019-02-09 03:10:24"
  ["add_date"]=>
  string(19) "2019-02-09 03:10:24"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:39"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1731"
  ["article_id"]=>
  string(4) "1731"
  [1]=>
  string(86) "NPA advises pharmacists to dispense medicines even if they receive FMD database alerts"
  ["article_title"]=>
  string(86) "NPA advises pharmacists to dispense medicines even if they receive FMD database alerts"
  [2]=>
  string(154) "The National Pharmacy Association has told its members to dispense medicines “even if they return an alert from the Falsified Medicines Directive da"
  ["short_description"]=>
  string(154) "The National Pharmacy Association has told its members to dispense medicines “even if they return an alert from the Falsified Medicines Directive da"
  [3]=>
  string(210) "The National Pharmacy Association has told its members to dispense medicines “even if they return an alert from the Falsified Medicines Directive database” in the early stages of its implementation."
  ["description"]=>
  string(210) "The National Pharmacy Association has told its members to dispense medicines “even if they return an alert from the Falsified Medicines Directive database” in the early stages of its implementation."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(165) "https://www.pharmaceutical-journal.com/news-and-analysis/news/npa-advises-pharmacists-to-dispense-medicines-even-if-they-receive-fmd-database-alerts/20206133.article"
  ["blog_url"]=>
  string(165) "https://www.pharmaceutical-journal.com/news-and-analysis/news/npa-advises-pharmacists-to-dispense-medicines-even-if-they-receive-fmd-database-alerts/20206133.article"
  [15]=>
  string(19) "2019-02-09 00:45:00"
  ["add_date"]=>
  string(19) "2019-02-09 00:45:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:36"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:36"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1732"
  ["article_id"]=>
  string(4) "1732"
  [1]=>
  string(89) "No-deal Brexit will be 'hair-raising' for pharmacists, says chief medical officer"
  ["article_title"]=>
  string(89) "No-deal Brexit will be 'hair-raising' for pharmacists, says chief medical officer"
  [2]=>
  string(158) "The prospect of medicines shortages following a no-deal Brexit on 29 March 2019 is “hair-raising” and pharmacists will be on the front line, the c"
  ["short_description"]=>
  string(158) "The prospect of medicines shortages following a no-deal Brexit on 29 March 2019 is “hair-raising” and pharmacists will be on the front line, the c"
  [3]=>
  string(200) "The prospect of medicines shortages following a no-deal Brexit on 29 March 2019 is “hair-raising” and pharmacists will be on the front line, the chief medical officer for England has said."
  ["description"]=>
  string(200) "The prospect of medicines shortages following a no-deal Brexit on 29 March 2019 is “hair-raising” and pharmacists will be on the front line, the chief medical officer for England has said."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(157) "https://www.pharmaceutical-journal.com/news-and-analysis/news/no-deal-brexit-will-be-hair-raising-for-pharmacists-says-chief-medical-officer/20206132.article"
  ["blog_url"]=>
  string(157) "https://www.pharmaceutical-journal.com/news-and-analysis/news/no-deal-brexit-will-be-hair-raising-for-pharmacists-says-chief-medical-officer/20206132.article"
  [15]=>
  string(19) "2019-02-08 23:37:00"
  ["add_date"]=>
  string(19) "2019-02-08 23:37:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:36"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:36"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}